ETF Holdings Breakdown of ARGX

ARGX institutional holdings

The adjusted close for ARGX on 2025-11-11 was 889.64

The following institutional investment holdings of ARGX have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	19,846	USD 17,655,795	889.64
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	19,846	USD 17,655,795 2.2%	889.64
Total =		39,692	USD 35,311,590

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with ARGX

Bank of America Raises argenex (NASDAQ:ARGX) Price Target to $887.00

argenex (NASDAQ:ARGX – Get Free Report) had its target price increased by equities researchers at Bank of America from $880.00 to $887.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Bank of America‘s target price would suggest a potential upside of 22.85% from the stock’s […] - 2025-09-04 04:34:49

Wedbush Estimates argenex’s Q3 Earnings (NASDAQ:ARGX)

argenex SE (NASDAQ:ARGX – Free Report) – Analysts at Wedbush reduced their Q3 2025 earnings per share (EPS) estimates for argenex in a research report issued to clients and investors on Monday, August 25th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of $5.60 per share for the quarter, down from […] - 2025-08-28 02:22:48

argenex (NASDAQ:ARGX) versus MaxCyte (NASDAQ:MXCT) Head to Head Analysis

MaxCyte (NASDAQ:MXCT – Get Free Report) and argenex (NASDAQ:ARGX – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations and dividends. Risk and Volatility MaxCyte has a beta of 1.23, meaning […] - 2025-08-27 04:50:47

argenex (NASDAQ:ARGX) Price Target Raised to $820.00

argenex (NASDAQ:ARGX – Free Report) had its target price raised by Piper Sandler from $750.00 to $820.00 in a research report report published on Tuesday,Benzinga reports. Piper Sandler currently has an overweight rating on the stock. Several other analysts also recently weighed in on ARGX. Oppenheimer lifted their price objective on shares of argenex from […] - 2025-08-27 03:06:44

argenex (NASDAQ:ARGX) Earns “Outperform” Rating from Wedbush

argenex (NASDAQ:ARGX – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at Wedbush in a note issued to investors on Monday,RTT News reports. They currently have a $800.00 target price on the stock. Wedbush’s price objective points to a potential upside of 12.98% from the stock’s previous close. ARGX has been […] - 2025-08-27 02:08:54

argenex (NASDAQ:ARGX) Now Covered by Analysts at Royal Bank Of Canada

Royal Bank Of Canada initiated coverage on shares of argenex (NASDAQ:ARGX – Free Report) in a research report report published on Monday, Marketbeat Ratings reports. The firm issued an outperform rating and a $850.00 price target on the stock. ARGX has been the subject of several other reports. Guggenheim increased their price objective on shares […] - 2025-08-26 03:10:54

Argenx's VYVGART Achieves Primary Endpoint In Pivotal Study For AChR-Ab Seronegative GMG

(RTTNews) - argenx SE (ARGX) reported that the pivotal ADAPT SERON study of VYVGART (IV: efgartigimod alfa-fcab) successfully met its primary endpoint. The study demonstrated a statistically significant and clinically meaningful improvement in MG-ADL (Myasthenia Gravis Activities - 2025-08-25 02:25:55

LPL Financial LLC Has $12.36 Million Position in argenex SE (NASDAQ:ARGX)

LPL Financial LLC lifted its holdings in shares of argenex SE (NASDAQ:ARGX – Free Report) by 28.0% during the first quarter, HoldingsChannel reports. The firm owned 20,880 shares of the company’s stock after acquiring an additional 4,563 shares during the quarter. LPL Financial LLC’s holdings in argenex were worth $12,358,000 as of its most recent […] - 2025-08-08 04:28:56

US Bancorp DE Sells 45 Shares of argenex SE (NASDAQ:ARGX)

US Bancorp DE decreased its stake in argenex SE (NASDAQ:ARGX – Free Report) by 0.9% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 4,835 shares of the company’s stock after selling 45 shares during the period. US Bancorp DE’s holdings in argenex were worth $2,862,000 as of its most recent filing with the […] - 2025-08-07 05:20:51

argenex SE (NASDAQ:ARGX) Stake Lowered by Avantax Advisory Services Inc.

Avantax Advisory Services Inc. reduced its stake in shares of argenex SE (NASDAQ:ARGX – Free Report) by 5.7% during the 1st quarter, HoldingsChannel reports. The fund owned 1,000 shares of the company’s stock after selling 61 shares during the period. Avantax Advisory Services Inc.’s holdings in argenex were worth $592,000 as of its most recent […] - 2025-08-05 05:52:53

Bank of New York Mellon Corp Buys 7,921 Shares of argenex SE (NASDAQ:ARGX)

Bank of New York Mellon Corp raised its holdings in shares of argenex SE (NASDAQ:ARGX – Free Report) by 124.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,283 shares of the company’s stock after buying an additional 7,921 shares […] - 2025-07-23 04:28:43

Ballentine Partners LLC Trims Stock Position in argenex SE (NASDAQ:ARGX)

Ballentine Partners LLC lessened its holdings in argenex SE (NASDAQ:ARGX – Free Report) by 7.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 495 shares of the company’s stock after selling 41 shares during the period. Ballentine Partners LLC’s holdings in argenex […] - 2025-07-17 05:33:09

argenex (NASDAQ:ARGX) Upgraded by Deutsche Bank Aktiengesellschaft to Buy Rating

Deutsche Bank Aktiengesellschaft upgraded shares of argenex (NASDAQ:ARGX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Tuesday, MarketBeat Ratings reports. Several other analysts have also recently weighed in on ARGX. HC Wainwright reissued a “buy” rating and issued a $720.00 price target on shares […] - 2025-07-11 02:36:48

2,640 Shares in argenex SE (NASDAQ:ARGX) Acquired by Calamos Advisors LLC

Calamos Advisors LLC purchased a new position in shares of argenex SE (NASDAQ:ARGX – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,640 shares of the company’s stock, valued at approximately $1,563,000. Other hedge funds and other institutional investors have […] - 2025-07-07 06:01:03

argenex (NASDAQ:ARGX) Now Covered by Analysts at Morgan Stanley

Morgan Stanley assumed coverage on shares of argenex (NASDAQ:ARGX – Free Report) in a report published on Thursday morning. The brokerage issued an overweight rating and a $700.00 target price on the stock. A number of other equities analysts have also weighed in on ARGX. Citigroup reiterated a “buy” rating on shares of argenex in […] - 2025-07-04 04:59:45

Janney Montgomery Scott LLC Boosts Stake in argenex SE (NASDAQ:ARGX)

Janney Montgomery Scott LLC increased its position in shares of argenex SE (NASDAQ:ARGX – Free Report) by 41.6% during the first quarter, HoldingsChannel reports. The institutional investor owned 1,141 shares of the company’s stock after buying an additional 335 shares during the quarter. Janney Montgomery Scott LLC’s holdings in argenex were worth $675,000 as of […] - 2025-07-02 05:37:06

Sequoia Financial Advisors LLC Boosts Stock Holdings in argenex SE (NASDAQ:ARGX)

Sequoia Financial Advisors LLC raised its stake in argenex SE (NASDAQ:ARGX – Free Report) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,829 shares of the company’s stock after acquiring an additional 24 shares during the period. Sequoia Financial Advisors LLC’s […] - 2025-07-01 05:50:51

Oppenheimer & Co. Inc. Has $542,000 Stock Position in argenex SE (NASDAQ:ARGX)

Oppenheimer & Co. Inc. lifted its stake in shares of argenex SE (NASDAQ:ARGX – Free Report) by 10.2% during the first quarter, Holdings Channel.com reports. The firm owned 915 shares of the company’s stock after acquiring an additional 85 shares during the period. Oppenheimer & Co. Inc.’s holdings in argenex were worth $542,000 as of […] - 2025-07-01 05:02:55

argenx SE (NASDAQ:ARGX) Receives Consensus Recommendation of “Buy” from Brokerages

argenx SE (NASDAQ:ARGX – Get Free Report) has been assigned a consensus rating of “Buy” from the twenty-two brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation, nineteen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. […] - 2025-06-16 02:52:48

HC Wainwright Reaffirms “Buy” Rating for argenx (NASDAQ:ARGX)

argenx (NASDAQ:ARGX – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $720.00 price objective on the stock. HC Wainwright’s price objective points to a potential upside of 25.23% from the stock’s previous close. A number […] - 2025-06-12 02:18:53

William Blair Estimates argenx’s Q2 Earnings (NASDAQ:ARGX)

argenx SE (NASDAQ:ARGX – Free Report) – Analysts at William Blair upped their Q2 2025 earnings estimates for shares of argenx in a note issued to investors on Thursday, May 29th. William Blair analyst M. Minter now expects that the company will earn $2.36 per share for the quarter, up from their previous estimate of […] - 2025-06-03 02:17:11

argenx SE (NASDAQ:ARGX) Receives Average Recommendation of “Buy” from Brokerages

argenx SE (NASDAQ:ARGX – Get Free Report) has been given an average rating of “Buy” by the twenty-three analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, twenty have given a buy recommendation and two have issued a strong buy recommendation on the […] - 2025-05-22 02:46:43

argenx (NASDAQ:ARGX) Upgraded to Outperform at Robert W. Baird

Robert W. Baird upgraded shares of argenx (NASDAQ:ARGX – Free Report) from a neutral rating to an outperform rating in a report issued on Tuesday, MarketBeat Ratings reports. Robert W. Baird currently has $680.00 price target on the stock. Other analysts have also recently issued research reports about the company. Oppenheimer raised their price objective […] - 2025-05-14 05:36:47

argenx SE (NASDAQ:ARGX) Receives $699.28 Average PT from Analysts

argenx SE (NASDAQ:ARGX – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-three research firms that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to […] - 2025-04-30 02:47:05

Argenx Secures CHMP Recommendation For European Approval Of VYVGART SC Injection For CIDP Treatment

(RTTNews) - argenx SE (ARGX) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended European Commission approval of VYVGART 1000mg (efgartigimod alfa). This subcutaneous (SC) injection is proposed as a monot - 2025-04-28 02:15:50

Cerity Partners LLC Sells 71 Shares of argenx SE (NASDAQ:ARGX)

Cerity Partners LLC cut its stake in shares of argenx SE (NASDAQ:ARGX – Free Report) by 2.2% during the 4th quarter, Holdings Channel reports. The fund owned 3,202 shares of the company’s stock after selling 71 shares during the period. Cerity Partners LLC’s holdings in argenx were worth $1,801,000 as of its most recent SEC […] - 2025-04-17 04:36:51

argenx SE (NASDAQ:ARGX) Receives Average Rating of “Moderate Buy” from Analysts

Shares of argenx SE (NASDAQ:ARGX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-three research firms that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong […] - 2025-04-02 04:16:47

Corient Private Wealth LLC Grows Stake in argenx SE (NASDAQ:ARGX)

Corient Private Wealth LLC grew its holdings in shares of argenx SE (NASDAQ:ARGX – Free Report) by 14.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,485 shares of the company’s stock after purchasing an additional 190 shares during the […] - 2025-03-28 06:14:57

argenx SE (NASDAQ:ARGX) Shares Purchased by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. increased its stake in shares of argenx SE (NASDAQ:ARGX – Free Report) by 7.9% in the 4th quarter, Holdings Channel reports. The firm owned 1,509 shares of the company’s stock after purchasing an additional 111 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in argenx were worth $928,000 at the […] - 2025-03-24 06:22:55

William Blair Comments on argenx’s Q4 Earnings (NASDAQ:ARGX)

argenx SE (NASDAQ:ARGX – Free Report) – Equities researchers at William Blair issued their Q4 2026 earnings estimates for argenx in a report released on Monday, March 17th. William Blair analyst M. Minter expects that the company will earn $7.29 per share for the quarter. William Blair has a “Outperform” rating on the stock. The […] - 2025-03-20 04:14:51

Back to Listing

Disclaimer